PR-Positive Breast Cancer
6 clinical trials · Condition
◉ Watch PR-Positive Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers (NCT04886531) | Ruth O'Regan | 2022-07-21 |
| Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer (NCT04504331) | Jennifer Lee Caswell-Jin | 2020-10-13 |
| A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) (NCT04504916) | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2020-10-07 |
Track PR-Positive Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.